By Natalija Farrell, PharmD, BCPS, DABAT *Editor's Note: This is the first post from our wonderful ED Pharmacist colleagues, and by our in-house toxicologist no less! Background: Hereditary angioedema (HAE) is a rare genetic disorder that results in recurrent episodes... Continue Reading →
By Zaid Altawil, MD Technology in medicine is advancing at ever faster rates, thanks to impressive (and exponential) progress in both cost and scale. Connected “Things” are getting smaller, cheaper, and more ubiquitous. If you don't believe me, check your... Continue Reading →
Resident Author: Madeline Brockberg, MD Faculty Editor: Steven Mcguire, DO An 86 year old male with a complicated past cardiac and GI history rolls into the resuscitation bay. He has a known history of afib on apixaban, prior esophageal cancer... Continue Reading →
There are only a few things I know about the world. Sunrise in the east, sunset in the west. Death and taxes. Cheese is definitely ok to toss on to your baby in a high chair, but probably not ok... Continue Reading →
There are only a few things I know about the world. Sunrise in the east, sunset in the west. Death and taxes. Black Friday at one time referred to a SINGLE day that came immediately after Thanksgiving. TL:DR – HEART... Continue Reading →
There are only a few things I know about the world. Sunrise in the east, sunset in the west. Death and taxes. Jennifer Garner was thinking about migraines. TL:DR – reglan, without benadryl. Decadron before they’re gone. Also try some... Continue Reading →
EM – Critical Care Journal Club Topic: Use of Thrombolytics in Submassive PE Article (2 of 4): Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M. Moderate Pulmonary Embolism Treated With Thrombolysis (from the “MOPETT” Trial). J Cardiol. 2013;... Continue Reading →
EM – Critical Care Journal Club Topic: Thrombolysis for sub-massive pulmonary embolism (PE) Article: Konstantinides, S.V., et. al. Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism. Journal of the American College of Cardiology. 2017. Volume 69,... Continue Reading →
EM – Critical Care Journal Club Topic: Use of tenecteplase in patients with intermediate-risk pulmonary embolism Article: Meyer et al. "Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism." NEJM 2014. Resident Reviewer: Emily Zametkin, MBBS Case / Problem Should we... Continue Reading →
